{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:31Z","timestamp":1790724091572,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"am","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","soard.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.soard.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:37:17Z","timestamp":1558352237000},"page":"1299-1310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-6248","authenticated-orcid":false,"given":"C\u00e9lia","family":"Lloret-Linares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Daali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-0369","authenticated-orcid":false,"given":"Claire","family":"Carette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bouillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Czernichow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"377","key":"10.1016\/j.soard.2019.05.019_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"9765","author":"Finucane","year":"2011","journal-title":"Lancet"},{"issue":"355","key":"10.1016\/j.soard.2019.05.019_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old","volume":"8","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"issue":"357","key":"10.1016\/j.soard.2019.05.019_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"8","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"issue":"153","key":"10.1016\/j.soard.2019.05.019_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamasurg.2017.6163","article-title":"Association between bariatric surgery and rates of continuation, discontinuation, or initiation of antidiabetes treatment 6 years later","volume":"6","author":"Thereaux","year":"2018","journal-title":"JAMA Surg"},{"issue":"23","key":"10.1016\/j.soard.2019.05.019_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11695-012-0864-0","article-title":"Metabolic\/bariatric surgery worldwide 2011","volume":"4","author":"Buchwald","year":"2013","journal-title":"Obes Surg"},{"issue":"13","key":"10.1016\/j.soard.2019.05.019_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.soard.2017.01.021","article-title":"Comparative effectiveness of primary bariatric operations in the United States","volume":"5","author":"Sudan","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"27","key":"10.1016\/j.soard.2019.05.019_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s11695-016-2535-z","article-title":"RYGB and drug disposition: how to do better? Analysis of pharmacokinetic studies and recommendations for clinical practice","volume":"4","author":"Hachon","year":"2017","journal-title":"Obes Surg"},{"issue":"64","key":"10.1016\/j.soard.2019.05.019_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.2042-7158.2012.01538.x","article-title":"A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3 A gut wall metabolism, permeability and dissolution","volume":"7","author":"Darwich","year":"2012","journal-title":"J Pharm Pharmacol"},{"issue":"82","key":"10.1016\/j.soard.2019.05.019_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.clpt.6100187","article-title":"Development of the \u201cInje cocktail\u201d for high-throughput evaluation of five human cytochrome P450 isoforms in\u00a0vivo","volume":"5","author":"Ryu","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"258","key":"10.1016\/j.soard.2019.05.019_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SLA.0b013e31827a0e82","article-title":"Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients","volume":"2","author":"Tandra","year":"2013","journal-title":"Ann Surg"},{"issue":"79","key":"10.1016\/j.soard.2019.05.019_bib11","article-title":"Phenotypic assessment of drug metabolic pathways and p-glycoprotein in patients treated with antidepressants in an ambulatory setting","volume":"2","author":"Lloret-Linares","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"96","key":"10.1016\/j.soard.2019.05.019_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/clpt.2014.83","article-title":"Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots","volume":"3","author":"Bosilkovska","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.soard.2019.05.019_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4155\/bio.13.289","article-title":"Simultaneous LC-MS\/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma","volume":"2","author":"Bosilkovska","year":"2014","journal-title":"Bioanalysis"},{"issue":"100","key":"10.1016\/j.soard.2019.05.019_bib14","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1002\/jps.22591","volume":"9","author":"Sakamoto","year":"2011","journal-title":"J Pharm Sci"},{"issue":"25","key":"10.1016\/j.soard.2019.05.019_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria","volume":"6","author":"Kamiie","year":"2008","journal-title":"Pharm Res"},{"issue":"80","key":"10.1016\/j.soard.2019.05.019_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/bcp.12666","article-title":"Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations","volume":"5","author":"Gesquiere","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"35","key":"10.1016\/j.soard.2019.05.019_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/phar.1560","article-title":"Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3 A4 and P-glycoprotein substrates","volume":"4","author":"Chan","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"32","key":"10.1016\/j.soard.2019.05.019_bib18","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1007\/s11095-015-1752-9","article-title":"The pharmacokinetics of the CYP3 a substrate midazolam in morbidly obese patients before and one year after bariatric surgery","volume":"12","author":"Brill","year":"2015","journal-title":"Pharm Res"},{"issue":"26","key":"10.1016\/j.soard.2019.05.019_bib19","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s11695-016-2065-8","article-title":"The effect of Roux-en-Y gastric bypass surgery in morbidly obese patients on pharmacokinetics of (acetyl)salicylic acid and omeprazole: the ERY-PAO study","volume":"9","author":"Mitrov-Winkelmolen","year":"2016","journal-title":"Obes Surg"},{"issue":"16","key":"10.1016\/j.soard.2019.05.019_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1018989211864","article-title":"Comparison of CYP2 D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines","volume":"8","author":"Madani","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.soard.2019.05.019_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2013.09.017","article-title":"Total gastrectomy may result in reduced drug effectiveness due to an increase in the expression of the drug-metabolizing enzyme cytochrome P450, in the liver","volume":"51","author":"Ishii","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.soard.2019.05.019_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.apsb.2016.07.012","article-title":"An update on the role of intestinal cytochrome P450 enzymes in drug disposition","volume":"5","author":"Xie","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"138","key":"10.1016\/j.soard.2019.05.019_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"1","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"53","key":"10.1016\/j.soard.2019.05.019_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40262-014-0163-0","article-title":"Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach","volume":"10","author":"Lloret-Linares","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"53","key":"10.1016\/j.soard.2019.05.019_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","article-title":"Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers","volume":"10","author":"Brill","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"75","key":"10.1016\/j.soard.2019.05.019_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3 A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens","volume":"3","author":"von Richter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.soard.2019.05.019_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3 A4 in the small and large human intestine","volume":"2","author":"Berggren","year":"2007","journal-title":"Mol Pharm"},{"issue":"33","key":"10.1016\/j.soard.2019.05.019_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/dmd.104.002469","article-title":"Do men and women differ in proximal small intestinal CYP3 A or P-glycoprotein expression?","volume":"3","author":"Paine","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"100","key":"10.1016\/j.soard.2019.05.019_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1742-7843.2006.00023.x","article-title":"Expression of cytochromes P450 3 A and P-glycoprotein in human large intestine in paired tumour and normal samples","volume":"4","author":"Canaparo","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"13","key":"10.1016\/j.soard.2019.05.019_bib30","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects","volume":"8","author":"Miyauchi","year":"2016","journal-title":"Mol Pharm"},{"issue":"16","key":"10.1016\/j.soard.2019.05.019_bib31","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: Comparison with MRM\/SRM and HR-MRM\/PRM","volume":"15-16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"issue":"25","key":"10.1016\/j.soard.2019.05.019_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2133\/dmpk.25.28","article-title":"Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions","volume":"1","author":"Galetin","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"issue":"41","key":"10.1016\/j.soard.2019.05.019_bib33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/dmd.112.050641","article-title":"Decreased CYP3 A expression and activity in guinea pig models of diet-induced metabolic syndrome: is fatty liver infiltration involved?","volume":"5","author":"Patoine","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.soard.2019.05.019_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cgh.2006.12.021","article-title":"Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3 A activity","volume":"3","author":"Kolwankar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"62","key":"10.1016\/j.soard.2019.05.019_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3 A4 and CYP3 A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"1","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"318","key":"10.1016\/j.soard.2019.05.019_bib36","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.106.106013","article-title":"Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism","volume":"3","author":"Galetin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"160","key":"10.1016\/j.soard.2019.05.019_bib37","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s12010-009-8689-6","article-title":"Role of human liver microsomes in in\u00a0vitro metabolism of drugs-a review","volume":"6","author":"Asha","year":"2010","journal-title":"Appl Biochem Biotechnol"},{"issue":"79","key":"10.1016\/j.soard.2019.05.019_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clpt.2005.11.004","volume":"3","author":"Oswald","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"99","key":"10.1016\/j.soard.2019.05.019_bib39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI119439","article-title":"Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3 A protein expression","volume":"10","author":"Lown","year":"1997","journal-title":"J Clin Invest"},{"issue":"26","key":"10.1016\/j.soard.2019.05.019_bib40","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s11095-009-9867-5","article-title":"MDR1 haplotypes conferring an increased expression of intestinal CYP3 A4 rather than MDR1 in female living-donor liver transplant patients","volume":"7","author":"Hosohata","year":"2009","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.soard.2019.05.019_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008571-200208000-00005","article-title":"C3435 T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3 A4 rather than Pgp in recipients of living-donor liver transplantation","volume":"6","author":"Goto","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"7","key":"10.1016\/j.soard.2019.05.019_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2174\/138920006779010575","article-title":"Xenobiotic-metabolizing enzymes in human lung","volume":"8","author":"Zhang","year":"2006","journal-title":"Curr Drug Metab"},{"issue":"279","key":"10.1016\/j.soard.2019.05.019_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.taap.2014.07.007","article-title":"Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models","volume":"3","author":"Van der Hauwaert","year":"2014","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728919301972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728919301972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:12:19Z","timestamp":1761552739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728919301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1550728919301972"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2019.05.019","relation":{},"ISSN":["1550-7289"],"issn-type":[{"value":"1550-7289","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of American Society for Bariatric Surgery.","name":"copyright","label":"Copyright"}]}}